23 results
8-K
EX-10.1
IMUX
Immunic Inc
12 Jun 20
Immunic, Inc. Announces Pricing of $25 Million Public Offering of Common Stock
4:05pm
Person and the Company, and such Indemnified Person shall have been advised in the reasonable opinion of counsel that there is an actual conflict … of interest that prevents the counsel selected by the Company from representing both the Company (or another client of such counsel) and any Indemnified
8-K
EX-10.4
IMUX
Immunic Inc
17 Jul 19
Updated Unaudited Pro Forma Condensed Combined Financial Information
5:15pm
not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing
8-K
EX-10.1
IMUX
Immunic Inc
27 Apr 20
Immunic, Inc. Announces Pricing of $15 Million Financing
5:00pm
Person and the Company, and such Indemnified Person shall have been advised in the reasonable opinion of counsel that there is an actual conflict … of interest that prevents the counsel selected by the Company from representing both the Company (or another client of such counsel) and any Indemnified
DEF 14A
wlztt hsk
7 Oct 15
Definitive proxy
12:00am
8-K
EX-3.2
ehkzec rv9zdd
17 Jul 19
Updated Unaudited Pro Forma Condensed Combined Financial Information
5:15pm
8-K
3onr9vb82zxfo
17 Jul 19
Updated Unaudited Pro Forma Condensed Combined Financial Information
5:15pm
424B4
deel7p39trxudv3
3 Oct 14
Prospectus supplement with pricing info
12:00am
424B4
rnqcwq62
17 Apr 14
Prospectus supplement with pricing info
12:00am